Groupe d'Etude en Oncologie du Quebec

Affichage 41 à 42 des 42 essais cliniques
1 | 2 | 3 | 4 | 5 |

ESSAIS CLINIQUES No essai ClinicalTrials.gov ID		Phase	Coordonnateur(rice)
(EN) A Phase III, Two-Arm, Parallel, Randomized, Multi-Center, Open-Label, Global Study to Determine the Efficacy of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for First-Line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer (mNSCLC). eVOLVE-Lung02 NCT05984277 Actif en recrutement	CISSS DE CHAUDIERE-APPALACHES HOTEL-DIEU DE LEVIS		Pierre Bédard 418-835-7121
(EN) A Phase 3, Multicenter, Randomized, Open-label Study Evaluating Efficacy of Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Subjects With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers, Negative for PD-L1, and Positive for KRAS p.G12C CodeBreaK 202 NCT05920356 Actif en recrutement	INSTITUT UNIVERSITAIRE DE CARDIOLOGIE ET DE PNEUMOLOGIE DE QUEBEC - UL		Brigitte Fortin 418-656-8711 poste 2639 Marie-Ève Morneau 418-656-8711 poste 2690

1 | 2 | 3 | 4 | 5 |

Groupe d'étude en oncologie du Québec